Literature DB >> 30370131

We should be done in such a way that patients with stage IV non-small cell lung cancer who would benefit from surgery are not overlooked.

Yasuhiro Chikaishi1, Ayako Hirai1, Naoko Imanishi1, Yoshinobu Ichiki1, Fumihiro Tanaka1.   

Abstract

Entities:  

Year:  2018        PMID： 30370131      PMCID： PMC6186621          DOI： 10.21037/jtd.2018.08.63

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

2.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 3.  Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).

Authors:  Kazue Yoneda; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  J UOEH       Date:  2018

4.  Non-Small Cell Lung Cancer, Version 6.2015.

Authors:  David S Ettinger; Douglas E Wood; Wallace Akerley; Lyudmila A Bazhenova; Hossein Borghaei; David Ross Camidge; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Thomas J Dilling; M Chris Dobelbower; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Lee M Krug; Rudy P Lackner; Michael Lanuti; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Steven E Schild; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-05       Impact factor: 11.908

Review 5.  Future scenarios for the treatment of advanced non-small cell lung cancer: focus on taxane-containing regimens.

Authors:  Francesco Grossi; Kaoru Kubota; Federico Cappuzzo; Filippo de Marinis; Cesare Gridelli; Marianna Aita; Jean-Yves Douillard
Journal:  Oncologist       Date:  2010-10-07

6.  Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.

Authors:  Vivien W Chen; Bernardo A Ruiz; Mei-Chin Hsieh; Xiao-Cheng Wu; Lynn A G Ries; Denise R Lewis
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

7.  Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.

Authors:  Y Ichinose; H Kato; T Koike; R Tsuchiya; T Fujisawa; N Shimizu; Y Watanabe; T Mitsudomi; M Yoshimura; M Tsuboi
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

Review 8.  Scientific Advances in Thoracic Oncology 2016.

Authors:  Ross A Soo; Emily C A Stone; K Michael Cummings; James R Jett; John K Field; Harry J M Groen; James L Mulshine; Yasushi Yatabe; Lukas Bubendorf; Sanja Dacic; Ramon Rami-Porta; Frank C Detterbeck; Eric Lim; Hisao Asamura; Jessica Donington; Heather A Wakelee; Yi-Long Wu; Kristin Higgins; Suresh Senan; Benjamin Solomon; Dong-Wan Kim; Melissa Johnson; James C H Yang; Lecia V Sequist; Alice T Shaw; Myung-Ju Ahn; Daniel B Costa; Jyoti D Patel; Leora Horn; Scott Gettinger; Solange Peters; Murry W Wynes; Corinne Faivre-Finn; Charles M Rudin; Anne Tsao; Paul Baas; Ronan J Kelly; Natasha B Leighl; Giorgio V Scagliotti; David R Gandara; Fred R Hirsch; David R Spigel
Journal:  J Thorac Oncol       Date:  2017-06-01       Impact factor: 15.609

9.  A prospective study of surgical procedures for patients with oligometastatic non-small cell lung cancer.

Authors:  Chiaki Endo; Tohru Hasumi; Yuji Matsumura; Nobuyuki Sato; Hiroyuki Deguchi; Hiroyuki Oizumi; Motoyasu Sagawa; Takao Tsushima; Satomi Takahashi; Jotaro Shibuya; Masahide Hirose; Takashi Kondo
Journal:  Ann Thorac Surg       Date:  2014-04-18       Impact factor: 4.330

10.  Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer.

Authors:  Yasuhiro Chikaishi; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Kazue Yoneda; Kouji Kuroda; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895
View more
  1 in total

Review 1.  The 100 most cited articles on thoracic surgery management of lung cancer.

Authors:  Ke Jin; Quanteng Hu; Jianfeng Xu; Chunlei Wu; Michael K Hsin; Carmelina C Zirafa; Nuria M Novoa; Stefano Bongiolatti; Robert J Cerfolio; Jianfei Shen; Dehua Ma
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.